Navigation Links
Pesticides choke pathway for nature to produce nitrogen for crops


Jennifer E. Fox, NIH/NRSA postdoctoral fellow at the University of Oregon, has shown that many pesticides interfere with the ability of legumes to recruit soil bacteria needed to provide a natural fertilizer to crops. Credit: University of Oregon
Many farmers applying pesticides to boost crop yields may instead be contributing to growth problems, scientists report in a new study.

According to years of research both in the test tube and, now, with real plants, a team of scientists reports that artificial chemicals in pesticides – through application or exposure to crops through runoff – disrupt natural nitrogen-fixing communications between crops and soil bacteria. The disruption results in lower yields or significantly delayed growth.

In a paper appearing online this week ahead of the regular publication by the Proceedings of the National Academy of Sciences (PNAS), the five-member team reports that agrichemicals bind to and block connections to specific receptors (NodD) inside rhizobia bacteria living in root nodules in the soil. Rotation legume crops such as alfalfa and soybeans require such interaction to naturally replace nitrogen levels that, in turn, benefit primary market crops like corn grown after legume rotations. __IMAGE_2

Legume plants secrete chemical signals that recruit the friendly bacteria, which work with the plants to convert atmospheric nitrogen into ammonia that, then, is used as fertilizer by the plants.

"Agrichemicals are blocking the host plant's phytochemical recruitment signal," said the study's lead author, Jennifer E. Fox, a postdoctoral researcher in the Center for Ecology and Evolutionary Biology at the University of Oregon. "In essence, the agrichemicals are cutting the lines of communication between the host plant and symbiotic bacteria. This is the mechanism by which these chemicals reduce symbiosis and nitrogen fixation."

'"/>

Source:University of Oregon


Page: 1 2 3

Related biology news :

1. Pesticides in the nations streams and ground water
2. Pesticides need sunscreen to beat the heat
3. Scientists find missing enzyme for tuberculosis iron scavenging pathway
4. Scientists identify genetic pathways essential to RNA interference
5. Opposing fat metabolism pathways triggered by a single gene
6. Viral protein influences key cell-signaling pathway
7. Newly discovered pathway might help in design of cancer drugs
8. Scientists identify genetic pathways essential to RNA interference
9. Genpathway and Baylor College of Medicine Identify New Genes in Breast Cancer
10. Scientists discover genetic pathway responsible for breast cancer cell growth
11. Bacteria that cause tooth decay able to survive without important biochemical pathway

Post Your Comments:
(Date:11/4/2009)...,, CARLSBAD, Calif., Oct. 23 Ge...ure biosample management for genomic discovery, me...vid Wellis, Ph.D., GenVault,s President and CEO, w...e taking place on October 26th and 27th in La Joll...ill provide an overview of the company together wi...
(Date:11/4/2009)...,, NEW YORK, Oct. 27 Global Rai...mpany and advanced R&D laboratory, today annou...e and is prepared to actively commercialize its su...dge biometric security offerings. ,, During the...llions of dollars to develop and deploy a series o...
(Date:11/4/2009)...,, CARLSBAD, Calif., Nov. 4 Gen...hat William Brody, M.D., Ph.D., has joined its Boa...idential Chair of the Salk Institute, is an acclai...ior to joining the Salk Institute, Dr. Brody serve...e is a member of the National Academy of Engineeri...
Breaking Biology News(10 mins):GenVault Corporation to Present at the 2009 BIOCOM Investor Conference 2Global Rainmakers Brings Cutting-Edge Biometric Security Products to Reality 2Global Rainmakers Brings Cutting-Edge Biometric Security Products to Reality 3Dr. William Brody, President of the Salk Institute for Biological Studies, Appointed to GenVault's Board of Directors 2Dr. William Brody, President of the Salk Institute for Biological Studies, Appointed to GenVault's Board of Directors 3Secretary Shinseki Moves to Simplify PTSD Compensation Rules 55136 1Secretary Shinseki Moves to Simplify PTSD Compensation Rules 55136 2Grammy 28R 29 Nominated R 26B Sensation Angie Stone Teams up With the American Diabetes Association to Encourage African Americans to be Victorious in 55133 1Grammy 28R 29 Nominated R 26B Sensation Angie Stone Teams up With the American Diabetes Association to Encourage African Americans to be Victorious in 55133 2Grammy 28R 29 Nominated R 26B Sensation Angie Stone Teams up With the American Diabetes Association to Encourage African Americans to be Victorious in 55133 3Grammy 28R 29 Nominated R 26B Sensation Angie Stone Teams up With the American Diabetes Association to Encourage African Americans to be Victorious in 55133 4IDEV 28R 29 Technologies Announces First Patient Enrolled in Multi Center Clinical Trial of SUPERA 28R 29 PERipheral Stent 4886 1IDEV 28R 29 Technologies Announces First Patient Enrolled in Multi Center Clinical Trial of SUPERA 28R 29 PERipheral Stent 4886 2
...mall molecules containing platinum, Virginia Commo...s have created a process to inhibit a class of pro...may help researchers develop new drugs to fight HI...n as zinc fingers. , In the May 30 issue of the j...ed that a zinc finger protein, known as HIV NCp7, ...
...earcher Zafira Castaño has discovered that the los...favors tumor growth. This was the conclusion that ...tion which she defended at the University of Navar...h prior studies from her laboratory, which demonst...cells that coat the normal lung, and which, nevert...
...ty crayfish - a voracious, bullying exotic that ha...akes - may have finally met its match. , Since it... 1950s, the crayfish has spread to thousands of la...sts that are critical fish habitat, evicting the n...r and scooping up fish eggs like so much caviar. ...
Other Biology News:New protein target may advance design of HIV and cancer drugs 2Study shows hope for ridding lakes of clawed invader 2Study shows hope for ridding lakes of clawed invader 3
(Date:11/6/2009)...PRNewswire-FirstCall/ -- BioSpecifics Technologies...ny developing first-in-class collagenase-based pro...he third quarter ended September 30, 2009. ,, ...s year, the FDA,s Arthritis Advisory Committee una...val of XIAFLEX(TM) for the treatment of Dupuytren,...
(Date:11/6/2009)...ov. 6 Calbiotech, Inc. announced t...ovative Research (SBIR) Phase I contract by the U....er terms of the agreement, Calbiotech will develop...s of Dengue virus. ,, Dengue virus is a mosq...t to military forces deployed to tropical areas of...
(Date:11/5/2009)...5 GenVec, Inc. (Nasdaq: ...the third quarter ended September 30, 2009. GenVec...are) for the three months ended September 30, 2009... share) in the comparable quarter of 2008. For the...t loss was $14.1 million ($0.15 per share), compar...
(Date:11/5/2009)...day, November 5, 2009 at 4:30 p.m. Eastern Time ,...FirstCall/ - OncoGenex Pharmaceuticals, Inc. ("Onc...eported unaudited financial results for the third ...nd reviewed the Company,s highlights for the third... results reflect the operations of OncoGenex Techn...
Breaking Biology Technology:Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 2Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 3Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 4Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 5Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 6Calbiotech Awarded U.S. Army Phase I SBIR Research Contract to Develop Analyte Specific Reagents for the Diagnosis of Dengue Fever Virus 2GenVec Reports Third Quarter 2009 Financial Results 2GenVec Reports Third Quarter 2009 Financial Results 3GenVec Reports Third Quarter 2009 Financial Results 4GenVec Reports Third Quarter 2009 Financial Results 5GenVec Reports Third Quarter 2009 Financial Results 6OncoGenex Reports Third Quarter 2009 Financial Results 2OncoGenex Reports Third Quarter 2009 Financial Results 3OncoGenex Reports Third Quarter 2009 Financial Results 4OncoGenex Reports Third Quarter 2009 Financial Results 5OncoGenex Reports Third Quarter 2009 Financial Results 6OncoGenex Reports Third Quarter 2009 Financial Results 7OncoGenex Reports Third Quarter 2009 Financial Results 8
...s., Oct. 31 Idenix,Pharmaceuticals, Inc., (Nasdaq...financial results for the third quarter of 2007 on... markets close. In conjunction with the issuance ...a conference call at 4:30 p.m. ET on Tuesday, Nove...sults for the third quarter,2007. To access the c...
...ct. 31 Modigene Inc. (OTC,Bulletin Board: MODG) t...,at the Acumen BioFin Rodman & Renshaw 9th Annual ...07 at 1:40 pm ET. The conference will be held at,t...ne CEO Abraham Havron and President Shai Novik wil...ew and review of corporate,developments. The pres...
.... 31 Anadys Pharmaceuticals,Inc. (Nasdaq: ANDS )...n,BioFin(TM) Rodman & Renshaw 9th Annual Healthcar...p.m. EST (1:25 p.m. PST). The conference is being,... Ph.D., President and Chief Executive Officer of A...ew of Anadys and its two,development-stage product...
Other Biology Technology:Modigene to Present at Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference 2Anadys Pharmaceuticals to Present at the Acumen BioFin Rodman & Renshaw Healthcare Conference 2
...lasma Immunodepletion Kit specifically removes 20 ... serum in preparation for further proteomics analy...o the plasma proteome whether you use one- or two-...ional chromatography or go straight to mass spectr...
...ntroduced the industry's first siRNA sequence desi... keep these tools consistent with new experimental...field of RNAi. With the introduction of our new, ...ine is pleased to offer the most significant advan...
... Signal Enhancer does for enzyme-/substrate-based ...ive blotting it increases the signal up to 10-fol... ,The Western Blot Signal Enhancer membrane treat...added to your current Western blotting protocol. ...
pYES2/CT from Invitrogen
Biology Products: